Moderna, Inc. Research And Development Expense

• Moderna, Inc. showed a decrease of -31.1% in Research And Development Expense from 2024 to 2025.
• This data is from Moderna, Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Moderna, Inc.'s Research And Development Expense has grown by 1,040.1%.
• Historical annual values: Fiscal year 2025: $3.13 billion | Fiscal year 2024: $4.54 billion | Fiscal year 2023: $4.85 billion | Fiscal year 2022: $3.30 billion | Fiscal year 2021: $1.99 billion | Fiscal year 2020: $1.37 billion | Fiscal year 2019: $496.00 million | Fiscal year 2018: $454.08 million | Fiscal year 2017: $410.46 million | Fiscal year 2016: $274.72 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026